DarioHealth Corp. (NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new employers and a new provider partner channel to provide the Company's digital therapeutic solutions beginning in the first quarter of 2022.
Dario's multi-chronic digital therapeutics platform includes programs for diabetes, pre-diabetes, hypertension, weight management, musculoskeletal and behavioral health integrated across one AI-driven behavior change engine. This single platform approach ensures participants in any program receive holistic digital and live behavior change support informed by data from the more than 208,000 users across all solutions to encourage lasting changes.
The new employer clients include a southwest regional employer in the health care industry contracting for behavioral health, and a midwestern employer in the food industry contracting for behavioral health with Employee Assistance Programs (EAPs).
The new provider contract gives Dario access to a wide range of providers through a unique strategic partnership that will launch with Dario's Remote Patient Monitoring (RPM) solution for hypertension in one practice in California, before expanding access to additional practices throughout 2022.
The diversity of the conditions across the three contracts further demonstrates the power of having a multi-condition platform.
"These contracts come at a time of rapidly accelerating growth for Dario as we start realizing the potential across our entire suite of solutions. Dario's growing track record of winning new business is building a steady pipeline of new membership across products, and we are excited to see our user base grow substantially in 2022," said Rick Anderson, President and General Manager North America.